Metraipolis › archive › dc_49fea840bd11

Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy — Europe PMC PMID:42652206

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42652206
DOI
10.3390/biomedicines14081825
License (as archived)
solo-consultazione
Archived
2026-10-16T15:55:52.554Z
SHA-256 of the archived text
705343fa398bb2594407eb93448ea6274bd2c50c8a1fc6ef489c9ae09f6c282d
Stable URL of this page
https://metraipolis.com/documento/dc_49fea840bd11

How to cite

Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy — Europe PMC PMID:42652206 — Europe PMC (en), https://europepmc.org/article/MED/42652206 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49fea840bd11 (Metraipolis archive dc_49fea840bd11, sha256 705343fa398bb2594407eb93448ea6274bd2c50c8a1fc6ef489c9ae09f6c282d)
BibTeX
@misc{dc49fea840bd11,
  title = {Comparative Prognostic Value of Systemic Inflammation-Based Biomarkers in Advanced Non-Small Cell Lung Cancer Treated with First-Line Immunotherapy — Europe PMC PMID:42652206},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42652206},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49fea840bd11; sha256 705343fa398bb2594407eb93448ea6274bd2c50c8a1fc6ef489c9ae09f6c282d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42652206. Agents can read the archived copy with the MCP tool read_document.